Antithrombotic therapy after infrainguinal bypass

Slides:

Advertisements

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Advertisements

Thomas F. O’Donnell, MD, Joseph Lau, MD Journal of Vascular Surgery

Combined endovenous laser therapy and microphlebectomy in the treatment of varicose veins: Efficacy and complications of a large single-center experience

Without prejudice Journal of Vascular Surgery

Comparison of popliteal artery aneurysm therapies

Peter J. Fahner, MD, Mirza M. Idu, MD, PhD, Thomas M

Flow measurement before and after papaverine injection in above-knee prosthetic femoropopliteal bypass Gustav Pedersen, MD, Elin Laxdal, MD, Svein Roar.

Outcome of infra-inguinal bypass grafts using vein conduit with less than 3 millimeters diameter in critical leg ischemia Hani Slim, MD, MRCS, Alok Tiwari,

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Tim J. van Oostenbrugge, MD, Jean-Paul P. M

Vein harvesting technique for infrainguinal arterial bypass with great saphenous vein and its association with surgical site infection and graft patency

Thrombolysis for deep venous thrombosis

Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010 Grant H. Skrepnek, PhD, David G. Armstrong,

Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage Caren Randon, MD, Bart Jacobs, MD, Frederik.

Breakthrough: Arthur Blakemore and Arthur Voorhees, Jr

Thomas F. O’Donnell, MD, Joseph Lau, MD Journal of Vascular Surgery

Mohamed A. Zayed, MD, PhD, Ronald L. Dalman, MD, Jason T. Lee, MD

Effect of anticoagulation on endothermal ablation of the great saphenous vein Mohsen Sharifi, MD, Mahshid Mehdipour, Curt Bay, PhD, Farnaz Emrani, BS,

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial Jill.

The learning curve of robot-assisted laparoscopic aortofemoral bypass grafting for aortoiliac occlusive disease Tomáš Novotný, MD, Martin Dvořák, MD,

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

Early duplex scanning after infrainguinal endovascular therapy

The first operation on the profunda femoris artery

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Without prejudice Journal of Vascular Surgery

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery Toshifumi Kudo, MD, PhD,

Efficacy of duplex ultrasound surveillance after infrainguinal vein bypass may be enhanced by identification of characteristics predictive of graft stenosis.

Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization Gregory S. Cherr, MD, Jiping Wang, MD,

Circulating inflammatory cells are associated with vein graft stenosis

Open versus endovascular treatment of subclavian artery atherosclerotic disease George C. Galyfos, MD, PhD, Ioannis Kakisis, MD, PhD, Chrisostomos Maltezos,

A comparison of patency and interventions in thigh versus Hemodialysis Reliable Outflow grafts for chronic hemodialysis vascular access Evan R. Brownie,

Thrombolysis for lower extremity bypass graft occlusion

Cryopreserved saphenous vein graft in infrainguinal bypass

Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients Mario Monaco, MD, Luigi Di Tommaso, MD,

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The future of vascular surgery

Optimal conduit choice in the absence of single-segment great saphenous vein for below-knee popliteal bypass James T. McPhee, MD, Neal R. Barshes, MD,

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

Update in preoperative risk assessment in vascular surgery patients

Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass.

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic.

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: Results of primary and secondary procedures Hans Schweiger, MD,

Analysis of 30-day readmission after aortoiliac and infrainguinal revascularization using the American College of Surgeons National Surgical Quality Improvement.

James T. McPhee, MD, Philip P

Peter Neglén, MD, PhD, Kathryn C. Hollis, BA, Seshadri Raju, MD

Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease Brant W. Ullery,

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial Michael S. Conte,

Reply Journal of Vascular Surgery

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

Paclitaxel-coated versus plain balloon angioplasty in the treatment of infrainguinal vein bypass stenosis Klaus Linni, MD, Ara Ugurluoglu, MD, Manuela.

Reviewer Acknowledgment

Philip P. Goodney, MD, MS, Adam W. Beck, MD, Jan Nagle, MS, RPh, H

James T. McPhee, MD, Louis L. Nguyen, MD, MBA, MPH, Karen J. Ho, MD, C

Endoscopic vein harvest for infrainguinal arterial bypass

Composite sequential bypasses to the ankle and beyond for limb salvage

Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy Paul A. Armstrong, DO, Dennis F. Bandyk,

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Efficacy of axillary-to-femoral vein bypass in relieving venous hypertension in dialysis patients with symptomatic central vein occlusion Joshua C. Grimm,

The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure Robert Scott Brumberg, DO, Martin R. Back,

Philip P. Goodney, MD, MS, Brian W

Bhagwan Satiani, MD, MBA, Thomas E. Williams, MD, PhD, Michael R

Fate of the contralateral leg after infrainguinal bypass

Luke S. Erdoes, MD, Timothy P. Milner, MD Journal of Vascular Surgery

Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions Alan B. Lumsden, MD, Eugene R. Heyman, PhD Journal.

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

John F. Eidt, MD, Elliot Chaikof, MD, PhD, Anton N. Sidawy, MD, MPH

Presentation transcript:

Antithrombotic therapy after infrainguinal bypass Mario Maufus, MD, Gilles Pernod, MD, PhD Journal of Vascular Surgery Volume 60, Issue 5, Pages 1367-1375 (November 2014) DOI: 10.1016/j.jvs.2014.07.105 Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 1 Efficacy and tolerance of antithrombotic drugs reported for all infrainguinal bypasses. The open boxes indicate occlusion/amputation, and the black boxes indicate hemorrhages. Patency was reported at 3 years,a 1 year,b 5 years,c and 2 years,d as originally reported. The relative risk (RR) or hazard ratio (HR) are shown as originally reported when available or the RR was calculated from the original data.*Occlusion was reported based on the analysis of primary and primary assisted patency. ¤Includes death, and gastrointestinal (GI), central nervous system (CNS), and genitourinary (GU) complications. ASA, Acetylsalicylic acid; CASA, combination of clopidogrel and acetylsalicylic acid; W, warfarin; WASA, combination of warfarin and aspirin. Journal of Vascular Surgery 2014 60, 1367-1375DOI: (10.1016/j.jvs.2014.07.105) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 2 Efficacy and tolerance of antithrombotic drugs reported for venous infrainguinal bypasses. The open boxes are for occlusion/amputation, and the black boxes are for hemorrhages. Patency was reported at 3 years,a 1 year,b 5 years,c and 2 years,d as originally reported. The relative risk (RR) or hazard ratio (HR) are shown as originally reported when available, or the RR was calculated from the original data.*Occlusion was reported based on the analysis of primary and primary assisted patency. ¤Includes death and gastrointestinal (GI), central nervous system (CNS), and genitourinary (GU) complications. ASA, Acetylsalicylic acid; CASA, combination of clopidogrel and acetylsalicylic acid; W, warfarin; WASA, combination of warfarin and aspirin. Journal of Vascular Surgery 2014 60, 1367-1375DOI: (10.1016/j.jvs.2014.07.105) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 3 Efficacy and tolerance of antithrombotic drugs reported for prosthetic infrainguinal bypasses. The open boxes are for occlusion/amputation, and the black boxes are for hemorrhages. Patency was reported at 1 year,a 5 years,b and 2 years,c as originally reported. The relative risk (RR) or hazard ratio (HR) are shown as originally reported when available, or the RR was calculated from the original data. *Occlusion was reported based on the analysis of primary and primary assisted patency. ¤Includes death and gastrointestinal (GI), central nervous system (CNS) and genitourinary (GU) complications. Journal of Vascular Surgery 2014 60, 1367-1375DOI: (10.1016/j.jvs.2014.07.105) Copyright © 2014 Society for Vascular Surgery Terms and Conditions